Jane Street’s Insys Therapeutics, Inc. INSY Stock Holding History

Jane Street’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-11,161	Closed	-$113K	–	6168
2018 Q3	$113K	Buy	+11,161	New	+$89K	﹤0.01%	4835
2018 Q1	–	Sell	-18,658	Closed	-$179K	–	5746
2017 Q4	$179K	Buy	+18,658	New	+$122K	﹤0.01%	4249
2016 Q4	–	Sell	-10,899	Closed	-$128K	–	4868
2016 Q3	$128K	Buy	+10,899	New	+$166K	﹤0.01%	3814
2016 Q1	–	Sell	-11,796	Closed	-$338K	–	4884
2015 Q4	$338K	Sell	11,796 -30,819	-72%	-$854K	﹤0.01%	2952
2015 Q3	$1.21M	Buy	42,615 +21,708	+104%	+$799K	0.01%	1456
2015 Q2	$751K	Buy	20,907 +13,193	+171%	+$411K	﹤0.01%	1861
2015 Q1	$224K	Sell	7,714 -7,026	-48%	-$186K	﹤0.01%	2786
2014 Q4	$311K	Buy	14,740 +3,700	+34%	+$73.2K	﹤0.01%	1857
2014 Q3	$214K	Buy	+11,040	New	+$173K	﹤0.01%	2175
2014 Q1	–	Sell	-26,232	Closed	-$338K	–	3238
2013 Q4	$338K	Buy	+26,232	New	+$364K	﹤0.01%	1550

Other funds holding INSY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Jane Street's INSY Position: Q4 2018 in Review

Jane Street sold out of Insys Therapeutics, Inc. (INSY) in Q4 2018, closing a stake of 11,161 shares — an estimated $113K sold.

Jane Street first reported a position in INSY in Q4 2013 and held it in 10 quarters. The position peaked at $1.21M in Q3 2015. 113 funds tracked by Wall St. Rank hold INSY as of Q4 2018.

Jane Street reported no remaining Insys Therapeutics, Inc. position as of Q4 2018 after selling out during the quarter.
Jane Street sold 11,161 Insys Therapeutics, Inc. shares in Q4 2018, an estimated $113K.
Jane Street first reported a position in Insys Therapeutics, Inc. in Q4 2013 and held it in 10 quarters.
Jane Street's Insys Therapeutics, Inc. position peaked at $1.21M in Q3 2015.
113 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q4 2018.

Based on Jane Street's 13F filing for Q4 2018, filed 15 Feb 2019.